PharmaSource: The External Manufacturing Community

Days

Hours

Minutes

Seconds

Your Biopharma Outsourcing Intelligence Hub

Trusted by 50,000+ biopharma manufacturing professionals Sign up for Newsletter

ERS Genomics Signs CRISPR Licensing Agreement with Aurigene Services

Vetter Breaks Ground on €500 Million Injectable Drug Facility in Germany

OrganaBio Acquires Excellos to Expand Cell Therapy CDMO Network

Elpida Therapeutics Selects Catalent for Late-Phase AAV Manufacturing

Charles River Laboratories Partners with MEDIPOST on Cell Therapy GMP Testing

CDMO consolidation drives PE toward equipment and consumables

ICON Opens 69,500 sq ft Early Phase CRU in San Antonio Alongside New Satellite Outpatient Clinics

Veeda Lifesciences and Agilent Launch Joint CRO Center of Excellence for GLP-1 and Complex Biologics Analytics

Understand Contract Packaging: Five Stages That Define a Successful Partnership

Trump Confirms Makary Exit; Diamantas Named Acting Chief

Andelyn Biosciences Launches LVV Curator Platform for Lentiviral Manufacturing

Vetter Breaks Ground on €500 Million Injectable Drug Facility in Germany

OrganaBio Acquires Excellos to Expand Cell Therapy CDMO Network

Elpida Therapeutics Selects Catalent for Late-Phase AAV Manufacturing

PODCASTS

How Kindeva’s $200M Sterile Injectable Investment Is Setting a New Compliance Benchmark for CDMOs

How PI Health Sciences Delivers Real-Time Visibility and Scientific Accountability

SPOTLIGHT

Why Compliance-Driven CDMOs Win Sponsor Contracts

RESOURCES

CDMO Contract Negotiations Timelines Explained

Target Product Profile (TPP) Explained

Why Compliance-Driven CDMOs Win Sponsor Contracts

UPCOMING EVENTS

PharmaSource: The External Manufacturing Community

ERS Genomics Signs CRISPR Licensing Agreement with Aurigene Services

ERS Genomics Signs CRISPR Licensing Agreement with Aurigene Services

Vetter Breaks Ground on €500 Million Injectable Drug Facility in Germany

OrganaBio Acquires Excellos to Expand Cell Therapy CDMO Network

Elpida Therapeutics Selects Catalent for Late-Phase AAV Manufacturing

Charles River Laboratories Partners with MEDIPOST on Cell Therapy GMP Testing

CDMO consolidation drives PE toward equipment and consumables

ICON Opens 69,500 sq ft Early Phase CRU in San Antonio Alongside New Satellite Outpatient Clinics

Veeda Lifesciences and Agilent Launch Joint CRO Center of Excellence for GLP-1 and Complex Biologics Analytics

Understand Contract Packaging: Five Stages That Define a Successful Partnership

Trump Confirms Makary Exit; Diamantas Named Acting Chief

Andelyn Biosciences Launches LVV Curator Platform for Lentiviral Manufacturing

Vetter Breaks Ground on €500 Million Injectable Drug Facility in Germany

OrganaBio Acquires Excellos to Expand Cell Therapy CDMO Network

Elpida Therapeutics Selects Catalent for Late-Phase AAV Manufacturing

How Kindeva’s $200M Sterile Injectable Investment Is Setting a New Compliance Benchmark for CDMOs

How PI Health Sciences Delivers Real-Time Visibility and Scientific Accountability

Why Compliance-Driven CDMOs Win Sponsor Contracts

CDMO Contract Negotiations Timelines Explained

Target Product Profile (TPP) Explained

Why Compliance-Driven CDMOs Win Sponsor Contracts

CDMO Live Europe 2026

External Manufacturing Leaders Rotterdam 2026

CDMO Live Americas 2026

External Manufacturing Leaders Boston 2026

Welcome to PharmaSource

Follow us

Top Links

Get in touch